Nauck, M. A. (2013). A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks. American Diabetes Association.
Dyfyniad Arddull ChicagoNauck, Michael A. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The Benefits By Far Outweigh the Potential Risks. American Diabetes Association, 2013.
Dyfyniad MLANauck, Michael A. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The Benefits By Far Outweigh the Potential Risks. American Diabetes Association, 2013.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.